These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12176610)

  • 1. Malignancy in organ transplantation: heart.
    Hunt SA
    Transplant Proc; 2002 Aug; 34(5):1874-6. PubMed ID: 12176610
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignancy after heart transplantation.
    Chen PL; Chang HH; Chen IM; Lai ST; Shih CC; Weng ZC; Hsieh YC; Yang AH
    J Chin Med Assoc; 2009 Nov; 72(11):588-93. PubMed ID: 19948436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy after heart transplantation: analysis of 24-year experience at a single center.
    Yagdi T; Sharples L; Tsui S; Large S; Parameshwar J
    J Card Surg; 2009; 24(5):572-9. PubMed ID: 19486222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant lymphoproliferative disorders in cardiac transplant patients.
    Fatio R; Sütsch G; Mayer K; Follath F; Corti R; Gallino A; Kiowski W
    Transplant Proc; 1998 Jun; 30(4):1118-20. PubMed ID: 9636453
    [No Abstract]   [Full Text] [Related]  

  • 6. Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients.
    Hsu RB; Chang CI; Tsai MK; Lee PH; Chou NK; Chi NH; Wang SS; Chu SH
    Eur J Cardiothorac Surg; 2010 May; 37(5):1117-21. PubMed ID: 20045346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.
    Ekman-Joelsson BM; Wåhlander H; Synnergren M; Sager M; Mellgren K
    Cardiol Young; 2017 Nov; 27(9):1823-1831. PubMed ID: 28780922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant lymphoproliferative disorders: report from a single center.
    De Carlis L; Slim AO; De Gasperi A; Muti G; Giacomoni A; Di Benedetto F; Lauterio A; Pirotta V; Corti A; Mazza E; Rondinara GF; Forti D
    Transplant Proc; 2001 Aug; 33(5):2815-6. PubMed ID: 11498170
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous lymphomas.
    Seçkin D; Hofbauer GF
    Cancer Treat Res; 2009; 146():343-51. PubMed ID: 19415215
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphoproliferative disorders after heart transplantation.
    Moyer P
    Lancet Oncol; 2006 Mar; 7(3):202. PubMed ID: 16538788
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor incidence in heart transplant patients: report of the North Italy Transplant Program Registry.
    Cardillo M; Rossini G; Scalamogna M; Pizzi C; Poli F; Piccolo G; Porta E; Malagò D; Taioli E; Fiocchi R; Sirchia G;
    Transplant Proc; 2001; 33(1-2):1840-3. PubMed ID: 11267536
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer After Heart Transplantation: A 25-year Single-center Perspective.
    Van Keer J; Droogné W; Van Cleemput J; Vörös G; Rega F; Meyns B; Janssens S; Vanhaecke J
    Transplant Proc; 2016; 48(6):2172-7. PubMed ID: 27569966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients.
    Kang W; Sampaio MS; Huang E; Bunnapradist S
    Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cancer in patients with renal transplants.
    Davison AM
    Adv Nephrol Necker Hosp; 1998; 28():171-94. PubMed ID: 9889990
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on pediatric heart transplantation. Long-term complications.
    Gajarski RJ; Kearney DL; Price JK; Denfield SW
    Tex Heart Inst J; 1997; 24(4):260-8. PubMed ID: 9456478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplantation Malignancy After Kidney Transplantation in Turkey.
    Keles Y; Tekin S; Duzenli M; Yuksel Y; Yücetin L; Dosemeci L; Sengul A; Demirbaş A; Tuncer M
    Transplant Proc; 2015 Jun; 47(5):1418-20. PubMed ID: 26093732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
    Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
    J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo malignancy after solid organ transplantation in children.
    Debray D; Baudouin V; Lacaille F; Charbit M; Rivet C; Harambat J; Iserin F; Di Filippo S; Guyot C;
    Transplant Proc; 2009 Mar; 41(2):674-5. PubMed ID: 19328954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signet ring cell primary cutaneous CD30+ lymphoproliferative disorder presenting as a monomorphic T-cell posttransplant lymphoproliferative disease.
    Papalas JA; Kulbacki EL; Park HK; Howell ER
    Am J Dermatopathol; 2012 Oct; 34(7):e94-6. PubMed ID: 22534639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphoproliferative disease and cancer in the transplant patient].
    Herreros J; Flórez S; Echevarría JR; Fernández AL; Pardo Mindán FJ
    Rev Esp Cardiol; 1995; 48 Suppl 7():129-34. PubMed ID: 8775827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.